Pain and the immune system.
In inflammation, leucocytes containing opioid peptides migrate into the tissue. Opioid peptides can be released and bind to opioid receptors on peripheral nerve terminals, which counteracts inflammatory pain. Migration of opioid peptide-containing leucocytes is controlled by chemokines and adhesion molecules. Neurokinins, such as, substance P also contribute to the recruitment of these cells. Opioid peptide release from granulocytes can be stimulated by chemokines, such as, CXCR2 ligands. The release is dependent on intracellular calcium and activation of phosphoinositol-3 kinase and p38 mitogen activated kinase. Endogenous opioid peptides produced by leucocytes not only confer analgesia but recent evidence supports the concept that they also prevent the development of tolerance at peripheral opioid receptors. This review presents the discoveries that led to the concept of analgesia produced by immune-derived opioids.
Rittner
H L
HL
Klinik für Anästhesiologie und operative Intensivmedizin, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30 D-12200, Berlin, Germany. heike.rittner@charite.de
Brack
A
A
Stein
C
C
D000701:Analgesics, Opioid / Q000627:therapeutic use; D000818:Animals; D002634:Chemotaxis, Leukocyte; D004361:Drug Tolerance; D006801:Humans; D007249:Inflammation / Q000276:immunology; D007962:Leukocytes / Q000378:metabolism / Q000502:physiology; D018847:Opioid Peptides / Q000378:metabolism; D010146:Pain / Q000188:drug therapy / Q000276:immunology*; D051381:Rats
D000701:Analgesics, Opioid; D018847:Opioid Peptides